Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

AriBio Signs $600M Deal for Alzheimer’s Drug with UAE.

Jun 10, 2025•about 1 year ago

Contract Type

contract

South KoreaBiotechnologyHealth CareTherapeutics

Description

AriBio has entered into a significant $600 million agreement focused on the development of a drug for Alzheimer's disease in partnership with the UAE. This contract marks a pivotal step in the pursuit of effective therapies for neurodegenerative diseases.

Company Information

Company

ARIBIO

Location

South Korea

About

ARIBIO is a biotechnology company focused on developing innovative solutions in the medical field. It has a strong commitment to advancing healthcare technologies. The company is actively pursuing strategic mergers to strengthen its market position. Its current priority is to merge with Solux.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for ARIBIO's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.